melanomaLung cancercancergenitourinarysolid organ malignanciesPembrolizumabIpilimumabAtezolizumabNivolumabMedicaid
…cy (n=13,497, 40.8%), followed by genitourinary (n=5,449, 16%), melanoma (n=4,442, 13%), gastrointestinal (n=4,103, 12%), and breast (n=…